Saturday 17 October 2026
Export AZTA’s income statement to Excel — free account
Azenta, Inc.
AZTA Healthcare Medical Instruments & Supplies
Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
34.09
2.43
−6.65%
Follow AZTA
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 | Sep '20 | Sep '19 | Sep '18 | Sep '17 | Sep '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 4 | 4 | 7 | 5 | 5 | 5 | 7 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 1.51 | 68.69 | 52.57 | 6.11 | 20.89 | 34.69 | 0.00 |
Altman Z-Score |
3.85 | 6.18 | 7.10 | 6.93 | 9.37 | 5.92 | 4.11 | 3.76 | 7.07 | 2.82 |
P/S ratio |
2.21 | 4.49 | 5.98 | 5.78 | 14.81 | 8.76 | 7.98 | 3.85 | 4.12 | 2.15 |
Altman Z″-Score (non-manufacturers) |
9.11 | 9.67 | 12.03 | 15.35 | 3.42 | 4.22 | 3.32 | 1.62 | 1.29 | 0.64 |
P/FCF ratio |
34.28 | 208.55 | 0.00 | 0.00 | 78.39 | 0.00 | 39.77 | 39.59 | 26.00 | 31.60 |
P/Operating CF |
605.41 | 146.42 | 116.70 | 333.20 | 280.60 | 65.69 | 81.63 | 77.86 | 62.34 | 39.78 |
Beneish M-Score |
(2.63) | (2.61) | (2.40) | (1.46) | (2.81) | (2.98) | (1.96) | (2.52) | (3.13) | (3.12) |
P/B ratio |
0.76 | 1.46 | 1.30 | 0.95 | 5.74 | 2.80 | 2.34 | 3.38 | 3.57 | 1.68 |
Price to Tangible BV |
1.42 | 2.71 | 2.26 | 1.20 | 11.36 | 6.21 | 6.68 | 6.71 | 6.85 | 3.46 |
EV/Sales |
1.72 | 3.82 | 4.22 | 2.35 | 14.45 | 8.24 | 7.13 | 3.77 | 3.94 | 1.97 |
EV/EBITDA |
31.13 | 14.68 | 141.19 | 48.30 | 215.35 | 109.94 | 292.39 | 34.25 | 48.63 | 75.40 |
EV/Operating CF |
14.14 | 44.08 | 398.54 | (2.81) | 49.53 | 84.57 | 26.20 | 32.20 | 21.59 | 21.60 |
EV/FCF |
26.63 | 177.53 | (69.20) | (2.41) | 76.49 | (1,556.10) | 35.52 | 38.81 | 24.87 | 28.95 |
Quick Ratio |
2.08 | 2.97 | 5.59 | 9.18 | 1.03 | 1.64 | 1.84 | 2.24 | 1.33 | 1.60 |
Current Ratio |
2.98 | 4.04 | 6.73 | 10.67 | 2.25 | 3.08 | 2.38 | 3.43 | 2.40 | 2.50 |
Net Debt/EBITDA |
(10.47) | (2.90) | (62.09) | (72.12) | (5.37) | (6.88) | (34.95) | (0.69) | (2.38) | (7.51) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 2.73% | 3.23% | 3.37% | 17.90% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 | 0.27 | 0.00 | 0.00 |
Asset Turnover |
0.29 | 0.23 | 0.17 | 0.20 | 0.30 | 0.25 | 0.26 | 0.68 | 0.73 | 0.60 |
Operating CF/Net income |
(1.29) | (0.30) | (0.40) | (0.22) | 1.35 | 0.58 | 0.21 | 0.63 | 1.54 | (0.57) |
Capex/Depreciation |
(0.57) | (0.19) | (0.51) | (1.49) | (0.81) | (0.61) | (0.43) | (0.33) | (0.45) | (0.35) |
Interest Coverage |
— | — | (1.40) | (5.39) | (15.26) | (12.43) | (2.13) | 3.30 | 35.10 | (108.62) |
| (3.19%) | (7.67%) | (0.50%) | 90.98% | 8.72% | 5.51% | 47.12% | 17.59% | 10.78% | (11.72%) | |
| (2.68%) | (6.61%) | (0.44%) | 77.06% | 6.56% | 4.22% | 33.50% | 12.52% | 8.62% | (9.62%) | |
ROIC |
(1.21%) | (2.40%) | (2.53%) | (1.10%) | (1.70%) | (2.26%) | (3.47%) | 2.93% | 1.77% | (2.27%) |
Return on Tangible Assets |
(8.93%) | (21.07%) | (1.04%) | 89.49% | 19.67% | 12.30% | 91.98% | 25.37% | 23.90% | (29.64%) |
Average Days of Receivables |
93.37 | 113.32 | 103.60 | 107.60 | 85.18 | 89.05 | 180.88 | 72.35 | 64.67 | 89.46 |
Research and Development Expense of Revenue |
5.12% | 5.50% | 5.83% | 4.96% | 4.36% | 4.59% | 5.18% | 7.43% | 7.56% | 10.19% |
Selling, General and Administrative Expense of Revenue |
44.05% | 45.86% | 47.82% | 45.27% | 49.08% | 48.97% | 48.88% | 26.45% | 26.83% | 27.49% |
Intangible Assets out of Total Assets |
0.39 | 0.39 | 0.37 | 0.19 | 0.36 | 0.43 | 0.49 | 0.32 | 0.38 | 0.41 |
Share Based Compensation of Revenue |
3.52% | 2.52% | 1.70% | 1.92% | 5.34% | 4.20% | 6.02% | 3.14% | 3.28% | 2.70% |
Graham Net Nets |
0.29 | 0.19 | 0.32 | 0.66 | 0.04 | 0.09 | 0.10 | 0.08 | 0.09 | 0.18 |
Graham Number |
0.00 | 0.00 | 0.00 | 169.40 | 24.45 | 18.07 | 46.45 | 19.44 | 13.30 | 0.00 |
Earnings Yield |
(4.49%) | (6.13%) | (0.36%) | 66.26% | 1.46% | 1.90% | 16.37% | 4.79% | 2.88% | (7.49%) |
Free Cash Flow Yield |
2.92% | 0.48% | (1.02%) | (16.93%) | 1.28% | (0.06%) | 2.51% | 2.53% | 3.85% | 3.16% |
Revenue per Share |
12.98 | 10.78 | 8.32 | 7.42 | 6.92 | 5.28 | 4.64 | 8.96 | 7.58 | 6.34 |
Operating CF per Share |
1.58 | 0.94 | 0.09 | (6.22) | 2.02 | 0.51 | 1.26 | 1.05 | 1.38 | 0.58 |
Capex per Share |
(0.74) | (0.70) | (0.60) | (1.03) | (0.71) | (0.54) | (0.33) | (0.18) | (0.18) | (0.15) |
Free Cash Flow per Share |
0.84 | 0.23 | (0.51) | (7.26) | 1.31 | (0.03) | 0.93 | 0.87 | 1.20 | 0.43 |
Cash per Share |
7.50 | 8.15 | 15.43 | 26.07 | 3.16 | 3.41 | 4.66 | 3.46 | 1.46 | 1.24 |
Shareholders Equity per Share |
37.75 | 33.25 | 38.25 | 44.91 | 17.85 | 16.50 | 15.82 | 10.18 | 8.73 | 8.08 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
37.75 | 33.25 | 38.25 | 44.91 | 17.85 | 16.50 | 15.82 | 10.18 | 8.73 | 8.08 |
Free Cash Flow |
38.32 | 12.35 | (33.60) | (543.48) | 97.05 | (2.06) | 67.04 | 61.38 | 83.41 | 29.51 |
Working Capital |
470.67 | 626.94 | 1,208.03 | 2,228.80 | 432.28 | 438.34 | 374.88 | 399.44 | 205.00 | 179.54 |
Capital Expenditures |
(33.86) | (37.39) | (39.44) | (77.43) | (52.80) | (39.92) | (23.86) | (12.59) | (12.82) | (10.04) |
Net Current Asset Value |
375.74 | 500.61 | 1,067.74 | 2,106.61 | 283.19 | 303.80 | 270.10 | 186.63 | 192.79 | 167.12 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 75.83 | 145.09 | 0.00 |
Capex to Sales |
0.06 | 0.07 | 0.07 | 0.14 | 0.10 | 0.10 | 0.07 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 77.36 | 151.69 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.39 | 1.29 | 0.38 | 0.34 | 0.50 | 0.74 | 0.55 | 0.64 | 0.50 | 0.52 |
Cash ROIC |
1.85% | 0.56% | (0.94%) | (10.22%) | 6.03% | (0.14%) | 4.39% | 5.30% | 11.76% | 4.62% |
Accounts Receivable Turnover |
3.60 | 3.43 | 3.44 | 3.92 | 4.79 | 2.98 | 2.30 | 5.78 | 5.28 | 4.50 |
Accounts Payable Turnover |
9.11 | 9.22 | 8.39 | 7.40 | 7.93 | 5.12 | 3.85 | 8.22 | 7.28 | 6.45 |
Inventory Turnover |
4.42 | 3.20 | 2.92 | 4.11 | 5.54 | 3.17 | 2.03 | 4.52 | 3.96 | 2.87 |
Average Days of Payables |
42.56 | 38.17 | 41.84 | 47.04 | 57.29 | 43.33 | 107.76 | 42.35 | 54.54 | 54.13 |
Days of Inventory on Hand |
84.56 | 81.65 | 149.84 | 104.11 | 81.68 | 62.62 | 181.87 | 91.83 | 81.52 | 121.84 |
Average Receivables |
164.97 | 167.29 | 160.15 | 141.82 | 107.33 | 130.20 | 145.40 | 109.33 | 99.92 | 96.41 |
Average Payables |
35.53 | 34.57 | 37.23 | 40.51 | 34.02 | 42.30 | 51.82 | 46.91 | 45.11 | 43.01 |
Average Inventory |
73.14 | 99.76 | 106.87 | 72.97 | 48.76 | 68.29 | 98.22 | 85.19 | 82.98 | 96.60 |
Average Assets |
2,079.92 | 2,492.99 | 3,300.92 | 2,767.82 | 1,689.39 | 1,537.63 | 1,305.63 | 930.94 | 726.27 | 722.30 |
Average Common Equity |
1,747.42 | 2,151.17 | 2,948.94 | 2,344.36 | 1,269.47 | 1,176.28 | 928.39 | 662.74 | 580.67 | 592.87 |
Columns are period end dates